Answers are grounded in this paper and cite their sources.
Background: Vincristine, although used as a chemotherapy drug, has been reported to induce nephrotoxicity, while Zingiber officinale , a medicinal plant, possesses antioxidant, antiapoptotic, and antitumorigenic properties. Aim and Objectives: In this study, we examined the effects of Z. officinale against vincristine-induced kidney damage by analyzing renal function, enzymatic antioxidants, and renal tissue. Materials and Methods: Thirty adult Wistar rats, weighing between 140 g and 185 g, were assigned into six groups of five animals each. Groups A, B, C, D, E, and F received 1 ml of distilled water, 200 mg/kg of Z. officinale aqueous extract, 1000 mg/kg of Z. officinale aqueous extract, 50 μg/kg of vincristine only, 200 mg/kg of Z. officinale aqueous extract and 50 μg/kg of vincristine, and 1000 mg/kg of Z. officinale aqueous extract and 50 μg/kg of vincristine, respectively. Administration of vincristine was by a 10-day intraperitoneal injection, while that of Z. officinale was by gavage, for a period of 28 days. Food and water were provided across all groups, ad libitum . Results: Vincristine significantly ( P < 0.05) increased the levels of creatinine, urea, chloride, and malondialdehyde while having a reducing effect on the levels of superoxide dismutase and catalase. The histology revealed that vincristine caused a distortion of the renal architecture. Conclusion: The administration of Z. officinale mitigated the aforementioned debilitating effects of vincristine.
No takes yet. Share an insight, caveat, or question.
Ehimigbai et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: